Scaling Cell Therapy in Europe: Why the Biotech Act Must Keep Pace with Innovation
Some medical advances treat a disease. A rare few can end it. CAR T-cell therapy belongs to the second kind.
Read more
Health
Clinical Trials at the Heart of EU’s Competitiveness: Delivering on the Promise of the EU Biotech Act
EU’s life sciences sector is at a turning point. While the region continues to generate world-class science, it is increasingly
Read more
Building the future of health in Europe
Europe’s healthcare systems are among our greatest achievements. They are built on a simple promise: that people should receive the
Read more
Europe’s Quest for Health Sovereignty: Building the Next Generation of Biotechnology
Energy system integration in Europe – Decarbonization of the European economy
Read more
Strengthening Health Innovation and Biotechnology in the EU
Biotechnology has become one of the European Union’s most strategic sectors, driving innovation, economic growth, high-skilled employment, and global competitiveness.
Read more
Towards a Sovereign Health Union
With a provisional agreement on the Critical Medicines Act reached on 12 May 20261, Europe has taken a step forward
Read more
From Research Excellence to Industrial Scale-Up: enabling Europe’s biotech competitiveness – the Lovaltech experience
Europe’s ambition for health sovereignty will be judged on its ability to transform scientific excellence into industrial capacity that remains
Read more
Europe’s Quest for Health Sovereignty
Health sovereignty has emerged as one of the defining political challenges facing the European Union. The COVID-19 pandemic exposed the
Read more